Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction.
about
A simple parallel analytical method of prenatal screeningSpecific receptor subtype mediation of LPA-induced dual effects in cardiac fibroblastsRole of TAZ in Lysophosphatidic Acid-Induced Migration and Proliferation of Human Adipose-Derived Mesenchymal Stem Cells.Lysophosphatidic acid increases the electrophysiological instability of adult rabbit ventricular myocardium by augmenting L-type calcium currentThe impact of bioactive lipids on cardiovascular development.The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA.Lysophospholipid mediators in the vasculatureGαi2 signaling: friend or foe in cardiac injury and heart failure?Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions.Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosisLysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.The prognostic values of leukocyte Rho kinase activity in acute ischemic strokeRoles of LPA in ovarian cancer development and progression.Lysophosphatidic Acid Triggers Apoptosis in HeLa Cells through the Upregulation of Tumor Necrosis Factor Receptor Superfamily Member 21.Lysophosphatidic acid rescues bone mesenchymal stem cells from hydrogen peroxide-induced apoptosis.Cardiac-specific inactivation of LPP3 in mice leads to myocardial dysfunction and heart failure.Lysophosphatidic acid receptor mRNA levels in heart and white adipose tissue are associated with obesity in mice and humans.JALA Special Issue: New Developments in Biosensing Technologies.Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway
P2860
Q28247633-C37BE6AB-CCE3-4243-8F27-A1A058A63D95Q28569220-83F500F1-88AD-4DB1-969B-58550CA5D4B7Q33878267-29FD2A89-E6FF-48A6-9269-E3EABCD0F175Q34430249-C1267B17-9225-4EA1-9BA0-A97CE7D94224Q35173287-FE8683AF-300D-4A52-830B-077342137DF3Q35395358-85ABD6BC-F5CD-4139-A0F6-C6A1D350B1EAQ35533485-9085ED7A-FACE-4FB7-A3D4-8C7E1512F355Q35544075-432BB78E-F5D1-4F4F-A678-251B49139B01Q36265805-67F08237-CF57-4B1C-B623-25FC0413E125Q37119757-622E97FF-0789-4193-9637-235041BB3BE9Q37375487-0BEF59BF-660E-407C-90B0-3978123C154CQ37639858-7362C125-112E-427E-8DCE-7A806C2630E1Q37650618-B5E7F8F7-2539-40CA-B94B-1ADB189F444AQ37700010-9F7D0F7A-4E14-458F-A655-4FAC3FB90E3BQ41509350-E856E42B-3C31-47E4-BE3C-50F33CEB0AB5Q42169428-232054EF-EF3D-47F4-9B54-9BE5866A56DCQ47220587-4942A573-850E-4947-8795-B78DB6B8B88FQ51839677-B305970F-AA98-4AA9-8588-12D1B833FDFDQ52640499-63A3CD3A-6AE7-439C-ABE4-D6A8905A9AD5Q57073812-3C023F84-281B-4481-AE2E-7EEA3E5A1F3A
P2860
Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Serum lysophosphatidic acid co ...... h acute myocardial infarction.
@en
Serum lysophosphatidic acid co ...... h acute myocardial infarction.
@nl
type
label
Serum lysophosphatidic acid co ...... h acute myocardial infarction.
@en
Serum lysophosphatidic acid co ...... h acute myocardial infarction.
@nl
prefLabel
Serum lysophosphatidic acid co ...... h acute myocardial infarction.
@en
Serum lysophosphatidic acid co ...... h acute myocardial infarction.
@nl
P2093
P2860
P1476
Serum lysophosphatidic acid co ...... h acute myocardial infarction.
@en
P2093
P2860
P304
P356
10.1080/00365510310003265
P577
2003-01-01T00:00:00Z